InvestorsHub Logo
Followers 5
Posts 809
Boards Moderated 0
Alias Born 08/30/2017

Re: aphib post# 1414

Monday, 06/01/2020 9:17:14 AM

Monday, June 01, 2020 9:17:14 AM

Post# of 1739
Like my dad stated Evoke has been good to us shareholders. No large diluting and never a r/s used. I'am very grateful to Evoke always thinking about the company and its shareholders. Finally we all about to reap the great reward. The FDA has approve the name Gimoti for metoclopramide nasal spray form. Last year and the years before we didn't get no approval for FDA approval of the name for Evoke drug Gimoti. I believe they have already approve the drug Gimoti, and looking thorough the other things that need to meet FDA approval like the name of the drug and next step FDA approval of the manufacture to manufacture Gimoti (Metoclopramide nasal spray). We get news of the approval of manufacture company. then it's clear and smooth sailing for Evoke drug "Gimoti".
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVOK News